Cymbalta

Cymbalta Approved in Canada for Treating Osteoarthritis Knee Pain

The treatment represents a new use for the drug, which also is approved to treat depression and other ailments.

Eli Lilly Canada announced that Health Canada has approved Cymbalta (duloxetine hydrochloride) for the management of chronic pain associated with osteoarthritis (OA) of the knee, representing a new analgesic treatment option for patients suffering from the condition.

No votes yet
Syndicate content